Canada OK's OSI Pharma's Tarceva Drug
OSI Pharmaceuticals Inc. said Wednesday that Canadian regulators approved its Tarceva drug as a treatment for advanced or spreading lung cancer in...
Forbes.com: OSI Pharmaceuticals Defends Its Drug
...window...
BW Online | June 2, 2003 | Bear Stearns Ups OSI Pharmaceuticals...
• More Headlines. Bear Stearns raised its estimates on OSI Pharmaceuticals (OSIP )
OSI Pharmaceuticals
Gelclair® Clinical Programs ... OSI Pharmaceuticals - Clinical Portfolio ... Clinical Trials ... Research Reagents Program ... Medical Information
OSI Pharmaceuticals - Careers
Gelclair® Clinical Programs ... OSI Pharmaceuticals - Clinical Portfolio ... Clinical Trials ... Research Reagents Program ... Medical Information
(OSI) Pharmaceuticals - 2002 Annual Report
NEXT PAGE >>
(OSI) Pharmaceuticals - 2002 Annual Report
2002 Annual Report...
OSI Pharmaceuticals "outperform" | newratings.com
OSI Pharmaceuticals "outperform", Bear Stearns...
BW Online | August 19, 2002 | BoA Cuts OSI Pharmaceuticals to...
Damage Control in Japan • More Headlines. Banc of America downgraded OSI Pharmaceuticals (OSIP ) to market perform from buy.
Drug extends lung cancer patients' survival
Tarceva is distributed by Genentech and made by OSI Pharmaceuticals, which helped pay for the study.
NOTE: Please contact us right away if you'd like to make any changes to your listing.
Powered by Search Enhancement © 2005
Home | Index
|
|